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I.  A HISTORY AND BACKGROUND ON DIETARY SUPPLEMENTS 
As the pace of life speeds up, a greater number of adults are looking for that 
“quick fix” when it comes to their health and wellbeing. Fifty years ago, resorting 
to a pill or shake for breakfast would have been questionable; yet nowadays, 
sitting down for a hearty, nutrient dense meal is a rarity. Adults across the country 
are turning to meal replacements and dietary substitutes to fuel their lifestyles. 
Population ageing, retiring baby boomers and a rising awareness of diet-health 
related disease (e.g. obesity, diabetes) are the major driving forces behind the 
expansion of preventative consumption of dietary supplements as a proactive way 
of maintaining good health.1 Furthermore, there is a willingness to “try anything” 
in the search of managing ones chronic disease (patients with chronic diseases 
often take more supplements than the general population).2 People as a whole 
have greater general awareness of diet-health issues and trends toward proactive 
health behaviours have increased consumers’ demand for more products with 
identifiable health benefits.3 Whether ordered online or purchased at the drug 
store, adults have easy access to dietary supplements without a prescription, and 
most consume them without their health care provider’s advice or knowledge.4 
In 2016 the diet supplement business was responsible for employing more than 
750,000 people. The industry alone was worth $122 billion, and within the past 
two years “[that] number has continued to grow and prosper.”5 The effects on the 
U.S. economy are positive, but unfortunately, the public are at risk of suffering 
from the potential detrimental consequences that some of those supplements could 
have on one’s health. While there is an extensive use of dietary supplements, there 
is little quality standardization of these products, and it is difficult for health care 
professionals and consumers alike to discern their safety and quality.6 Although 
supplements cannot be marketed for the treatment or prevention of disease, they 
are often taken to address symptoms or illnesses, as well as to maintain or improve 
overall health.7 Even with this stipulation in place, “[a] 2003 review of claims 
made on 273 websites selling dietary supplements found that 55% of sites made 
unauthorized and illegal claims to treat, prevent, diagnose, or cure specific 
 
1 Gavura Scott, Who Takes Dietary Supplements, SCIENCE-BASED MEDICINE (Feb. 14, 
2013), https://sciencebasedmedicine.org/who-takes-dietary-supplements-and-why/.  
2 Falci L, Shi Z, Greenlee H., Multiple Chronic Conditions and Use of Complementary 
and Alternative Medicine Among US Adults: Results from the 2012 National Health 
Interview Survey (May 5, 2016), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858448/.  
3 Anders Sven, Schroeter Christiane, The Impact of Nutritional Supplement Intake on 
Diet Behaviour and Obesity Outcomes (Oct. 9, 2017), 
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0185258.  
4 Bailey Regan L., Gahche Jamie J., Miller Paige E., Why US Adults Use Dietary 
Supplements (Mar. 11, 2013), 
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1568520.  
5 Economic Impact of the Dietary Supplement, THE SCIENCE BEHIND THE SUPPLEMENTS, 
https://www.crnusa.org/resources/economic-impact-dietary-supplement-industry.  
6 Akabas, Sharon R. et al, Quality Certification Programs for Dietary Supplements, J. OF 
THE ACAD. OF NUTRITION AND DIETETICS, Vol. 116, Issue 9, 1378-79 (Sept. 2016).  
7 Bailey, supra note 4. 
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disease.”8 Furthermore, “[t]he Government Accountability Office found that one 
in five dietary supplements sold for weight loss or immune system support 
included prohibited disease-related claims on their labels.”9 Not only do such 
claims entice consumers to purchase the products, but they also put an 
unwarranted amount of risk on the consumer in putting their faith in the product 
when professional medical help may be the most beneficial avenue. Consumers 
often believe what they see on the label, and rely on those claims being made to 
them – when in reality, at best, such products are often just a band aid on the 
situation.10 Not only is there the possibility of falsified claims being made by 
manufacturers, but some companies have also contaminated their products with 
filler that were not listed within the ingredients. This came to fruition when 
investigators found powdered rice and laxatives in place of St John’s Wort,11 
 
8 Akshay Kapoor & Joshua M. Sharfstein., Breaking the Gridlock: Regulation of Dietary 
Supplements in the United States, WILEY ONLINE LIBR. (Nov. 2, 2015), 
https://onlinelibrary.wiley.com/doi/full/10.1002/dta.1892; see also CA Morris & J. 
Avorn, Internet Marketing of Herbal Products, PUBMED.GOV (Sept. 17, 2003), 
https://www.ncbi.nlm.nih.gov/pubmed/13129992.  
9 Morris, supra note 8, see also Office of Inspector Gen., Dietary Supplements: 
Structure/Function Claims Fail to Meet Federal Requirements, DEPT. OF HEALTH AND 
HUMAN SERVICES DIETARY SUPPLEMENTS, (Oct. 2012), 
https://oig.hhs.gov/oei/reports/oei-01-11-00210.pdf; see also Nadel Mark V., Committee 
on Labor and Human Resources, https://www.gao.gov/assets/90/83193.pdf (“[T]his was 
an issue even thirty years ago when dietary supplements were not widely used. From 
fiscal year 1989 to 1992, FDA had taken action against about 290 companies that 
manufactured or marketed dietary supplements. FDA took action against about 250 of the 
companies because I determined that their products’ labelling contained unsubstantiated 
drug claims and, thus, the products were new drugs that were misbranded. FDA took 
action against the remaining companies because it considered the substances in their 
products to be unsafe food additives because they were not generally regarded as safe and 
had not been approved by FDA for use in foods or their products’ labelling did not 
contain a complete list of ingredients.”) 
10 See generally Bill Fay, Average Doctor Visit Cost, DEBT.ORG, 
https://www.debt.org/medical/doctor-visit-costs/ (last updated Apr. 2, 2019). 
11 Steven G. Newmaster, et al., DNA Barcoding Detects Contamination and Substitution 
in North America Herbal Products, BMC MEDICINE (Oct. 11, 2013), 
https://doi.org/10.1186/1741-7015-11-222 (“[H]erbal products available to consumers in 
the marketplace may be contaminated or substituted with alternative plant species and 
fillers that are not listed on the labels. According to the World Health Organization, the 
adulteration of herbal products is a threat to consumer safety. Our research aimed to 
investigate herbal product integrity and authenticity with the goal of protecting 
consumers from health risks associated with product substitution and contamination.”)  
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black walnut in place of Ginkgo biloba,12 and various species of Asian actae in 
place of black cohosh.13  
 Nevertheless, strictly speaking about dietary supplements, consumers rely on 
the claims on the label and put their faith into the stipulated ingredients because 
they are not necessarily aware that dietary supplements - often sold within the 
same vicinity as FDA approved over-the-counter drugs - are not tested for safety 
or efficacy prior to market entry. 14  However, the perception of many is that 
anything on sale within the same purlieu of those over-the-counter drugs are as 
safe and as widely regulated.15  
A. Weight-Loss Supplements 
With the current obesity epidemic around the world, and particularly in the 
U.S.,16 many Americans turn to supplements to aid and accelerate their weight 
loss journey.17 The reason that many turn to supplements, is because not enough 
doctors treat obesity as a disease, and even those who do, cannot prescribe drugs 
 
12 Id., (Within the experiment, “[m]ost of the herbal products tested were of poor quality, 
including considerable production substitution, contamination and use of fillers. These 
activities dilute the effectiveness of otherwise useful remedies, lowering the perceived 
value of all related products because of a lack of consumer confidence in them. We 
suggest that the herbal industry should embrace DNA barcoding for authenticating herbal 
products through testing of raw materials used in manufacturing products. The use of an 
SRM DNA herbal barcode library for testing bulk materials could provide a method for 
‘best practices’ in the manufacturing of herbal products. This would provide consumers 
with safe, high quality herbal products.”)  
13 Id.; see also DA Baker, et al., DNA Barcode Identification of Black Cohosh Herbal 
Dietary Supplements, PUBMED.GOV, (last visited Sept. 8, 2019), 
https://www.ncbi.nlm.nih.gov/pubmed/22970567.  
14 Joanna K. Sax, Dietary Supplements are Not all Safe and Not all Food: How the Low 
Cost of Dietary Supplements Preys on the Consumer, AM. J. OF L. & MED. (Sept. 21, 
2015), https://doi.org/10.1177%2F0098858815591523.  
15 Id.; see also U.S. FOOD & DRUG ADMIN., Mixing Medications and Dietary Supplements 
Can Endanger Your HealthI, FDA, 
https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm420349.htm (last updated 
Oct. 27, 2014). 
16 CTRS. FOR DISEASE CONTROL AND PREVENTION, Obesity is Common, Serious, and 
Costly, CDC, (Aug. 13, 2018), https://www.cdc.gov/obesity/data/adult.html (“[T]he 
prevalence of obesity was 39.8% among adults and 18.5% among youth in the United 
States in 2015-2016. Obesity prevalence increased in both adults and youth during the 18 
years between 1999-2000 and 2015-2016”); see also NAT’L CTR. FOR HEALTH AND 
STATISTICS, Prevalence of Obesity Among Adults and Youth: United States, 2015-2016, 
(Oct. 2017) https://www.cdc.gov/nchs/data/databriefs/db288.pdf (‘Obesity prevalence 
increased in both adults and youth during the 18 years between 1999-2000 and 2015-
2016.”). 
17 Edward McKinley, As Obesity Rates in America Soar New Weight Loss Drugs are in 
the Offing that Offer Hope, CNBC (Dec. 22, 2018, 9:00 AM), 
https://www.cnbc.com/2018/12/12/new-obesity-drugs-are-coming-but-doctors-and-
insurers-are-hurdles.html (“In general, the way obesity medication works is either by 
affecting the brain or the gut. It can work on your brain to make you feel less hungry, on 
your intestines and gut to make you digest food more slowly, or some combination of the 
two.”). 
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to all but their wealthiest patients; with few insurers, and no government insurance 
program, offering coverage.18 In an industry-sponsored study, 3,500 Americans 
were surveyed about their use of dietary supplements for weight loss.19 The results 
of the study were worrying. A majority believed that not only were the weight-
loss supplements approved for safety and efficacy, but that these type of 
supplements were actually safer than over the counter or prescription 
medications.20  Based on these findings, it is not surprising that thousands of 
American’s are reluctant to seek medical advice about their weight and instead 
rely on manufacturers who claim to be the quick fix that they are looking for.21  
B. Dangers: Emergency Department Visits 
The obese population are not the only ones at risk. A recent study published 
in the New England Journal of Medicine found that adverse effects of dietary 
supplements were responsible for an average of about 23,000 emergency 
department (ED) visits per year. 22  Dietary supplements are best known for 
providing benefits to the human body; they should not put an unjustifiable amount 
of risk of those who are taking it. 23  Weight-loss products accounted for one 
quarter of all single-product ED visits and disproportionately affected women, 
 
18 Id. 
19 See Janine L. Pillitteri et al., Use of Dietary Supplements for Weight Loss in the United 
States: Results of a National Survey, WILEY ONLINE LIBR. (Sept. 6, 2012), 
https://onlinelibrary.wiley.com/doi/epdf/10.1038/oby.2007.136 (One noticeable result 
from the survey was that a higher proportion of African Americans and Hispanics used 
dietary supplements than did whites and additionally, those with less education, lower 
incomes, and no health insurance were more likely to use supplements. Finally, dietary 
supplements were more likely to be used by those who reported a greater number of 
lifetime weight-loss attempts, tried a greater number of weight loss products and 
methods, and reported greater willingness to see a doctor for assistance with weight loss.) 
20 Id.  
21 Id., (“[C]ertain groups that were surveyed were more likely to believe that dietary 
supplements are safe, efficacious, and regulated before marketing. These groups included 
younger respondents (aged 18-24 and 25-34 years vs. older age groups); African 
Americans, Hispanics, and other ethnicities (compared to whites); those with less 
education; and those without health insurance.”) 
22 Andrew I. Geller et al., Emergency Department Visits for Adverse Events Related to 
Dietary Supplements, N. ENG. J. MED. 373;16 (Oct. 15, 2015), 
https://www.nejm.org/doi/pdf/10.1056/NEJMsa1504267 (“[S]uch visits commonly 
involved cardiovascular manifestation from weight-loss or energy products among young 
adults and swallowing problems, often associated with micronutrients, among older 
adults.”) 
23 Id., (“[W]orryingly, unsupervised ingestions by children caused more than one fifth of 
all estimated emergency department visits for supplement-related adverse events, with 
almost two thirds involving micronutrients. Child-resistant packaging is not required for 
dietary supplements other than those containing iron”); see also Susan Farrell., Harmful 
Effects of Supplements Can Send you to the Emergency Department, HARV. MED. SCH. 
(Oct. 15, 2015), https://www.health.harvard.edu/blog/harmful-effects-of-supplements-
can-send-you-to-the-emergency-department-201510158434.  
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while men were more likely to experience adverse effects from products 
advertised for sexual enhancement and body building.24 
Apart from rapid weight loss, dietary supplements are often marketed to those 
individuals who work-out.25 These people are not looking for a quick fix in terms 
of their health; rather they are looking for an increase in their performance.26 
Unfortunately, those in that position often are young adults,27 and as demonstrated, 
those within that category are among the most likely to believe that dietary 
supplements go through the same rigorous regulation and testing by the FDA as 
do over-the-counter drugs.28  
1. Case Study: Matthew Dana 
Unfortunately, that lack of knowledge had detrimental effects on a young 
bodybuilder – Matthew Dana. In August 2017, Dana, a 27-year-old New York 
State Sergeant died after overdosing on a dietary supplement common in the 
bodybuilding field -  Kratom.29 Known as an energizer and pain reliever, it has 
been extensively used in the bodybuilding community to help lifters feel focused 
and energized.30  In 2017, Kratom was regarded as a dietary supplement and 
 
24 Farrell, supra note 23.   
25 Karimian, Jahangir, Esfahani, Parrivash S., Supplement Consumption in Body Builder 
Athletes, J. OF RES. AND MED SCI. (Oct. 2011), 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430026/ (In this study, a substantial 
number of bodybuilders took vitamins, minerals, and/or other supplements. “Among 
national-level Sri Lankan athletes, it was reported that 94% of the subjects had used 
supplements. In University students in U.S., 89% used dietary supplements. Additionally, 
like many other studies, men were more likely to take supplements than women.”) 
26 Id.; see also Frolad K., Koszewski W., Hingst J., Kopecky L., Nutritional Supplement 
use Among College Athletes and Their Sources of Information, INT’L. J. OF SPORT 
NUTRITION AND EXERCISE METABOLISM (Oct., 2004), 
https://www.ncbi.nlm.nih.gov/pubmed/15129934 (Reasons for supplement intake 
include; include increasing energy, enhancing performance, improving health, prevention 
of nutritional deficiencies, prevention of illness, increasing muscle mass, and improving 
recovery.) 
27 Kristiansen M., Levy-Milne R., Barr S., Flint A., Dietary Supplement use by Varsity 
Athletes at a Canadian University, INT’L. J. OF SPORT NUTRITION AND EXERCISE 
METABOLISM (Apr. 2015), 
https://pdfs.semanticscholar.org/cbb8/351840c623cbe4f626b998f1e5b80735d983.pdf 
(Among Canadians, 94.3% of young athletes were reported to have one or more 
supplement use.) 
28 CTRS. FOR DISEASE CONTROL AND PREVENTION, supra note 16.  
29Danielle Zickl, This Healthy 27-Year-Old Bodybuilder Died After Using a Common 
Supplement, MENS HEALTH (Oct. 3, 2017), https://www.menshealth.com/trending-
news/a19537222/police-officer-matthew-dana-kratom-bodybuilding-supplement-
overdose/.  
30 Id.; see also Joel Balsam, Police Sergeant Matt Danas’s Death Ruled A Kratom 
Overdose, ASK MEN (Oct. 2017), https://www.askmen.com/news/sports/police-sergeant-
matt-dana-s-death-ruled-a-kratom-overdose.html  (“In 2017, six states had banned 
Kratom and the Drug Enforcement Agency considered making it illegal nationwide, but 
decided to delay its decision in 2016 due to protests from Congress and the American 
Kratom Association.”) 
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therefore it had not been tested in the same clinical trials that other drugs are 
subjected to. Ultimately that means that the dietary supplement world had no idea 
exactly what would happen if someone were to take it over a long period of time 
or ingest a lot of it.31 It was not until September 2018 that the FDA released a 
statement regarding the ongoing concerns about the supplement.32 The Matthew 
Dana death revived the movement for Kratom to be labelled as an illegal substance; 
but this example shows that it should not require a death or a significant adverse 
health effect for the FDA to respond to such dietary supplements before removing 
them and banning them from production.33 This death could have been avoided if 
the proper science and testing had gone into regulating the dietary supplement 
before it was available to the public.  
II.  THE FDA’S CURRENT REGULATION 
Dietary supplements are classified as food. As defined in the U.S. Code, the 
term dietary supplement means a product (other than tobacco) intended to 
supplement the diet that bears or contains one or more of the following dietary 
ingredients: a vitamin; a mineral; a herb or other botanical; an amino acid; a 
dietary substance for use by man to supplement the diet by increasing the total 
dietary intake; or a concentrate, metabolite, constituent, extract, or combination 
of any ingredient described in clause (A), (B), (C), (D), or (E)34 The classification 
as a food rather than a drug is a huge problem and is one of the major reasons why 
the current standard in place is lacklustre when it comes to regulation, safety, and 
efficacy. Being classified as food is important for the FDA because there is no 
requirement that each supplement goes through the extensive regulatory process 
that prescription drugs do. That is not to say that dietary supplements are 
unregulated, and it is a free for all market - they are just not regulated to the degree 
that they should be. 
 
31Zickl, supra note 29. 
32 FDA Statement, Statements from FDA Commissioner Scott Gottlieb, M.D., on new 
warning letters FDA is issuing to companies marketing Kratom with unproven medical 
claims; and the agency’s ongoing concerns about Kratom (Sept. 11, 2018), 
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620106.htm 
(“[M]itragyna speciosa, known more commonly as Kratom, is a plant native to Thailand, 
Malaysia, Indonesia and Papua New Guinea. There is evidence that certain substances 
found in Kratom are opioids and data suggest that one or more may have a potential for 
abuse. The FDA is not alone in its concern about the opioids found in Kratom – it’s 
already illegal or controlled in several other countries including Australia, Denmark, 
Germany, Malaysia and Thailand. The substance is also banned in a number of states and 
municipalities in the U.S.”) 
33 Nat’l Ctr. for Complementary and Integrative Health, In the News: Kratom (Mitragyna 
species), NCCIH (Jun. 29, 2018), https://nccih.nih.gov/news/kratom (“[I]n June the FDA 
completed its investigation of Kratom. However, because of proponents of the plant, the 
banning of the substance all together did not carry forward. Therefore the FDA continues 
to actively evaluate all available scientific information on the issue and continues to warn 
consumers not to use any products labeled as containing the botanical substance Kratom 
or its psychoactive compounds. According to the most recent statement by Commissioner 
Gottlieb, the “FDA stands ready to evaluate evidence that could demonstrate a medicinal 
purpose for Kratom; however, the agency has received no such submissions and is not 
aware of any evidence that would meet the agency’s standard for approval.””)  
34  See 21 U.S.C. § 321 ff (2010).  
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A. A History of the Regulation 
Prior to any legislation, dietary supplements were regulated under the general 
food provisions of the FDA. “[T]he Pure Food and Drug Act of 1906 dealt with 
unsafe foods, unregulated elixirs, and misbranded products.”35 In 1941 the FDA 
promulgated the first recommended daily allowance regulations for vitamin and 
mineral supplements and other foods for special dietary needs containing added 
vitamins or minerals. “[However] these regulations placed no restriction on the 
amount or variety of nutrients that could be included in a supplement or a fortified 
food.”36 Furthermore, between 1962 and 1974, the FDA attempted to revise these 
regulations to replace the minimum daily requirements (MDR), with a new 
reference standard – the U.S. Recommended Daily Allowance (U.S. RDA) – and 
to establish a standard of identity restricting the amounts of combinations of 
vitamins and minerals that could be marketed as dietary supplements. The FDA 
also “proposed to require a label disclaimer on vitamin or mineral supplements.”37  
The nineties saw a huge reform and restructuring of dietary supplement 
regulation. In 1990, “Congress passed the Nutritional Labelling and Education 
Act (hereinafter ‘NLEA’), which affected the labelling of food and dietary 
supplements. The significance of the NLEA was that it mandated that virtually all 
food labels not only had to contain specific information on nutrient content, but 
they could also make claims relating to specific diseases or disorders.”38 “In 1992, 
Congress passed the Dietary Supplement Act which essentially prohibited the 
implementation of NLEA with respect to dietary supplements except for the 
approved health claims.”39 
In 1994, Congress passed, and President Clinton signed, the Dietary 
Supplement Health Education Act.40 The Act was established to “[t]o amend the 
Federal Food, Drug, and Cosmetic Act to establish standards with respect to 
dietary supplements, and for other purposes.” 41  In signing such legislation, 
President Clinton stated: 
After several years of intense efforts, manufacturers, experts in 
nutrition, and legislators – acting in a conscientious alliance with 
 
35 HEALTH.GOV, Report of the Commission on Dietary Supplements 11-17 (1997) 
https://health.gov/dietsupp/final.pdf.  
36 Id. 
37 Id., (“The disclaimer would state: ‘Vitamins and minerals are supplied in abundant 
amounts by commonly available foods. Except for persons with special medical needs, 
there is no scientific basis for recommending routine use of dietary supplements.”) 
38 Id., (“Such “health claims” were to be based on significant scientific agreement on the 
validity of the claimed relationship between the nutrient and the disease. In response to 
this, the FDA established standards for the types and levels of evidence necessary to meet 
the criteria for approval of health claims.”) 
39 Id., (“The following year the FDA published an extensive ANPR which was to 
pinpoint the current standards of regulation in the use of dietary supplements. This ANPR 
was a significant factor for the development and passage of the DSHEA in 1994.”) 
40 Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 108 Stat. 
4325 
41 Id. 
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consumers at the grassroots level – have moved to successfully bring 
common sense to the treatment of dietary supplements under regulation 
and law.42 
However, under the DSHEA, supplement manufactures still not need 
demonstrate safety or efficacy; “rather, the DSHEA purposefully minimizes 
oversight by the FDA and focuses on the value of the industry for the US 
economy.”43  
Manufacturers of dietary supplements containing ingredients that were 
introduced after October 15, 1994, (the enactment date of the DSHEA), were 
required to notify the FDA before marketing and to provide a rationale for the 
safety of the ingredients, such as historical use. However, neither safety testing 
nor FDA approval was required before the marketing of dietary supplements.44 
For those ingredients that were introduced before October 15, 1994, dietary 
supplement manufacturers were only responsible for establishing the safety and 
quality of a product, but they were not required to share that information with the 
FDA before the product entered the market.45 Because the “FDA has limited 
resources to ascertain harmful effects - products of dubious quality can stay in the 
market without consequence.”46 
It took until 2007 for a response when Congress finally passed the Dietary 
Supplement and Non-prescription Drug Consumer Protections Act (DSNDCP).47 
The law amended the Federal Food, Drug, and Cosmetic Act (FDCA) to require 
manufacturers of dietary supplements to report serious adverse events to the FDA. 
Prior to this law being passed, the FDA were under no obligation to collect adverse 
health occurrences from the manufactures; the only information they had access 
to respond to, was any complaints the public had put forward directly to the FDA. 
However, the passing of the DSNDCP went further. As Senator Richard Durbin 
said at the time, “[w]ith this bill, the FDA will have the tools to monitor 
 
42 HEALTH.GOV, supra note 35 (“The new legislation defines dietary supplements, places 
the responsibility for ensuring their safety on manufactures, identifies how literature may 
be used in connection with sales, specifies types of statements of nutritional support that 
may be made on labels, specifies certain labelling requirements, and provides for the 
establishment of regulations for good manufacturing practices.”) 
43 Ahar H. Bimal, The Dietary Supplement Health and Education Act: Time for a 
Reassessment. Comment on “Acute Selenium Toxicity Associated with Dietary 
Supplement,” JAMA NETWORK 
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/415585 (Feb. 8, 2010). 
44 New Dietary ingredients in Dietary Supplements – Background for Industry, FDA 
http://www.fda.gov/Food/DietarySupplements/NewDietaryIngredientsNotificationProces
s/ucm109764.htm (last visited Oct. 4, 2019).  
45 Jaap Venema, et al., Dietary Supplements Quality Analysis Tools from the United 
States Pharmacopeia, DRUG TEST ANALYSIS 
https://onlinelibrary.wiley.com/doi/full/10.1002/dta.1940 (last visited Mar. 2016). 
46 Id.  
47 Dietary Supplement and Nonprescription Drug Consumer Protection Act, Pub. L. No. 
109-462, 120 Stat. 3469. 
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supplements that cause dangerous health problems like heart attacks, strokes, 
seizures, and liver failure.”48 
In the same year, the FDA released regulations establishing standards for 
Current Good Manufacturing Practices (CGMPs) for dietary supplements. At the 
time, the current FDA Commissioner Andrew C. Von Eschenbach stated that the 
regulations would “help to ensure the quality of dietary supplements so that 
consumers could be confident that the products they purchase contained what is 
on the label.”49 
In 2011 the FDA released draft guidance that clarified what constituted a new 
dietary ingredient requiring additional assurances of safety and streamlined the 
necessary reporting structure. The agency’s press release called for “preventive 
control to ensure that consumers are not exposed to unnecessary public health 
risks from new ingredients with unknown safety profiles.”50 A worrying statistic 
to note is that despite the FDA’s new requirement to register new ingredients, 
even with the increase of 86,000 supplements on the market since 1994 when the 
DSHEA was passed, only 170 notifications of new ingredients were received.51 A 
majority of the market value is covered by only about 100 ingredients (e.g. fish 
oil, calcium, glucosamine/chondroitin, CoQ10, and ginkgo), and major product 
categories (e.g. multivitamins, sports nutrition, and probiotics).52 
III.  THE METHOD’S ALREADY IN PLACE 
In an ideal world, all manufacturers would follow the guidance, legislation, 
and rules that has accumulated over the years. The responsibility is in the hands 
of the manufacturer when it comes to the supplements themselves.53 Even with 
the CGMPs and DSHEA, there are still three main areas left untouched; “(1) they 
do not limit consumers’ access to dietary supplements; (2) they do not address the 
safety of the supplements’ ingredients; and (3) they do not address the 
 
48 R. Durbin, U.S. Senate Committee on Environment & Public Works: Durbin Dedicates 
Dietary Supplements Legislation (2006), 
https://www.epw.senate.gov/fact.cfm?party=rep&id=267066.  
49 Press Release, FDA Issues Dietary Supplements Final Rule, (Jun. 22, 2007), 
http://www.fda.gov/NewsEvents/Newsroom/PressAnnoucnements/2007/ucm108938.  
50 U.S. Food and Drug Administration, Press Release: FDA Issues Anti-Smuggling 
Strategy and Draft Guidance on New Dietary Ingredients (Jul. 5, 2011), 
https://www.prnewswire.com/news-releases/fda-issues-anti-smuggling-strategy-and-
draft-guidance-on-new-dietary-ingredients-125011839.html.  
51 See generally Pieter A. Cohen, et al., Presence of Banned Drugs in Dietary 
Supplements Following FDA Recalls, JAMA NETWORK (Oct. 22, 2014), 
https://jamanetwork.com/journals/jama/fullarticle/1917421.  
52 Zickl, supra note 28. 
53 Editorial Content Team, Manufacturing Guidelines for Dietary Supplements, U.S. 
CANCER SOC’Y (Mar. 31, 2015), https://www.cancer.org/treatment/treatments-and-side-
effects/complementary-and-alternative-medicine/dietary-supplements/manufacturing-
guidelines.html (“Many manufacturers have always followed careful consistent standards 
and sell only high-quality, correctly labeled supplements. But there are manufacturers out 
there who are less careful and end up making supplements that contain little or none of 
the products listed on the label. It is important to keep in mind that despite the continuous 
accumulation of regulation many supplements are still found to be tainted with real drugs 
or dangerous substances as not all manufactures follow the rules.”) 
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supplements’ effects on the body as long as good manufacturing processes are 
used.”54 The danger with these three areas left open, especially (2), is that criminal 
manufacturers still have the potential to get their product onto the market as only 
after it is on the market will the FDA have the power to remove it.  
Honest manufacturers and those who pride themselves on standardized quality 
do have options to show the consumers that they are doing all they can to remain 
an integral part of the industry. Manufacturers can register with the United States 
Pharmacopeial Convention (USP) - an independent, non-profit, scientific-based 
organization, which has worked with volunteer experts from a wide cross-section 
of stakeholders to develop and continuously revise and update science-based 
quality standards for medicines, including their test methods and other tools that 
help protect public health.55 Since 1992, USP has developed the science-based 
quality standards for nutritional and dietary supplements following an open and 
transparent public consultation process, whereby input from manufacturers, 
regulators, suppliers, and any other interested party is considered and evaluated 
by volunteer experts organized in expert committees. The USP admission 
evaluation process involves consideration of safety information from multiple 
sources, including adverse event reports from FDA MedWatch.56 The relevance 
for consumers is that they can go into any store that the USP website lists as 
having safe products with the awareness those products have been tested and have 
gone through an assessment.57  
The assessment is conducted for the sole purpose of determining whether or 
not to develop a compendial monograph that is admitted in the United States 
Pharmacopeia-National Formulary (USP-NF), however this is not intended as a 
determination of the intrinsic safety or efficacy of the dietary supplement 
ingredient or product under review. The USP-NF collaboration is recognised as 
official compendia of the United States.58 The USP-NF contains standards for 
medicines, dosage forms, drug substances, excipients, biologics, compounded 
preparations, medical devices, dietary supplements, and other therapeutics. Over 
the counter drugs are required to be in compliance with these standards - whereas, 
 
54 Id.  
55 U.S. Pharmacopeia, Dietary Supplements Compendium, USP 
http://www.usp.org/products/dietary-supplements-compendium (last visited Oct. 9, 
2019); see also U.S. Pharmacopeia, Dietary Supplements Verification Program, USP 
http://www.usp.org/verification-services/dietary-supplements-verification-program (last 
visited Oct. 9, 2019) (Dietary Supplement Verification Program Participants include the 
following top manufacturers; Church & Dwight Co., Inc., Cyanotech Corporation, 
MeriCal Inc., and Nutrawise Corporation). 
56 USP, Guideline for the Admission of Dietary Supplement Ingredients to the USP-NF 
Monograph Development Process (Feb. 5, 2017), 
https://www.usp.org/sites/default/files/usp/document/get-involved/submission-
guidelines/guideline-for-the-admission-of-dietary-supplement-ingredients.pdf.  
57 U.S. Pharmacopeia, USP Dietary Supplement Verified, QUALITY SUPPLEMENTS, 
https://www.quality-supplements.org/verified-products/verified-retailers (last visited Oct. 
9, 2019) (Retailers that carry USP verified products include BJ’s Wholesale Club, Costco 
Wholesale Club, HEB, K-Mart, Kroger, Meijer, Sam’s Club, Target, Walgreens and 
Walmart.) 
58 Federal Food, Drug, Cosmetic Act, 21 U.S.C.S. § 321(j) (LexisNexis 2019).  
[2019]                        KENNETT, TIME FOR CHANGE 
 
57 
dietary supplements have the option. 59  It is unsurprising that many diet 
supplement manufacturers typically avoid going through the USP-NF process to 
avoid any risk of not meeting the compliance.  
The importance of this process is that under the DSHEA, if a dietary 
supplement manufacturer has gone through the USP-NF protocol and has gone on 
to brand their product as doing one thing, but in fact it does not, then that dietary 
supplement may be deemed misbranded because it has failed to comply with an 
official compendium. 60 In essence, despite the good intentions from the DSHEA 
in misbranding products that do not conform to the standards that they claim to 
have under the USP-NF, they are just disincentivising manufacturers from going 
through this process due to the risk of being misbranded. It is safer for them to 
brand their product in getting as many purchasers as possible and waiting for them 
to bring the product to the attention of the FDA.  
IV.  WHY REFORM IS NEEDED 
A. Unsafe Until Proven Safe vs. Safe Until Proven Unsafe 
Today there is a disproportionate standard being applied to prescription/over-
the-counter drugs and dietary supplements. Two out of the three have the 
obligation to go through clinical processes, be certified by the official United 
States Compendia, and to go through extensive testing to prove that what it says 
on the label is in fact what the product contains/does. The combination of the 
processes that prescription and OTC drugs have to go through ensure that what 
the consumer is administering has in fact been proven to be safe for their health. 
The outlier here is the lack-lustre regulation of dietary supplements. Since 1962, 
the FDA has required that prescription drugs demonstrate safety and efficacy 
through standard means of evaluation before they can be used by the public.61 
Sixty years on and the FDA still does not require dietary supplements to go 
through the same extensive testing as prescription or OTC drugs. Dietary 
supplements are still labelled as a food despite being taken to have more of the 
same effect as drugs rather than food.62 Considering a supplement unsafe until 
proven safe is a standard that should have been cemented into the industry a long 
time ago.63  
 
59 U.S. Pharmacopeia, Dietary Supplements & Herbal Medicines, USP 
http://www.usp.org/dietary-supplements-herbal-medicines (last visited Oct. 9, 2019) (To 
protect and improve their health, many people purchase dietary supplements and herbal 
medicines over the counter – often assuming they’re regulated like drugs. While the law 
requires pharmaceuticals to meet specific quality standards set by USP, the same 
requirements don’t apply to supplements.) 
60 Zickl, supra note 28. 
61 Kefauver-Harris Amendments Revolutionized Drug Development, FDA (last modified 
Oct. 10, 2012), https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm322856.htm.  
62 Editorial Content Team, Drugs are Considered Unsafe Until Proven Safe, U.S. 
CANCER SOC’Y (Mar. 31, 2015), https://www.cancer.org/treatment/treatments-and-side-
effects/complementary-and-alternative-medicine/dietary-supplements/fda-
regulations.html (“[B]ecause supplements aren’t considered drugs, they aren’t put 
through the same strict safety and effectiveness requirements that drugs are. So all the 
drugs you can buy, even without a prescription, must be proven safe and effective – but 
dietary supplements do not.”) 
63 Id., (This will all begin with the FDA changing their classification from food. This 
paper is not to say that the classification should explicitly fall within the drug category, 
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As more people reach for the easiest option when it comes staying healthy, the 
Government and the FDA need to realise that categorizing dietary supplements as 
food is neither suitable nor effective. This issue needs to be attacked with 
aggression and force to protect the public. A stronger relationship with the FDA 
is needed to establish a screening process that dietary supplement manufacturers 
need to go through in order to get their ingredients tested and their products 
labelled correctly in a similar way that drugs are.64 This paper is not setting forth 
a requirement that dietary supplements go through the exact same protocols and 
testing as drugs due to time and money/resource restraints. What this paper is 
proposing is a happy medium – so consumers are aware of the side effects and the 
FDA can continue to follow up on new products to see how they are performing 
on the market.65 
B. Current Drug FDA Regulation vs. Dietary Supplement Regulation 
The time it takes for a new drug to get onto the market can be years. The 
weight on the FDA’s shoulder’s is immense because the public are putting their 
faith in the agency in making sure that what they are buying from the store or what 
they are being prescribed by their doctor is safe and reliable to be taken in 
accordance with their illness. The journey of a drug reaching the market “follows 
a cyclical path of proposal, modification, and re-proposal until, finally, they reach 
a decision on the product and create regulations.”66 
The major difference between drugs and dietary supplements as, already 
demonstrated, is that “the FDA only approves drugs if they are deemed both safe 
and effective for their intended purpose.”67 Once a drug has been approved, the 
FDA is “then responsible for regulating the drug which includes ensuring that the 
 
but dietary supplements need to escape from the bubble that encompasses the same 
regulations as food.)  
64 Editorial Content Team, FDA Regulation of Drugs Versus Dietary Supplements, Drugs 
are considered unsafe until proven safe, U.S. CANCER SOC’Y (Mar. 31, 2015), 
https://www.cancer.org/treatment/treatments-and-side-effects/complementary-and-
alternative-medicine/dietary-supplements/fda-regulations.html (One the FDA approves 
the drug, it must be manufactured under carefully monitored conditions and packaged 
with complete information on the best dose, route, and schedule. The package 
information must also include: conditions the drug has been proven to treat, known side 
effects, contraindications (special conditions under which using the drug should not be 
used because it would cause too much risk), and unsafe interactions with other drugs.)  
65 Id., (Once the general public is using a new drug, the FDA follows up on any ill effects 
patients and their doctors report. The drug company is required to file information they 
get about side effects as well. This data helps ensure that any side effects not seen in the 
clinical trials will eventually be found and tracked for the safety of other people.)  
66 Michael Moneheit, How the FDA Regulates Drugs, THE DOCTOR WEIGHS IN, 
https://thedoctorweighsin.com/how-the-fda-regulates-drugs/ (last modified Aug. 26, 
2016) (Before the FDA gets involved, scientists must develop and test a drug on animals, 
after which point a drug company becomes involved to design a prototype of the drug. 
The same drug company must then file an Investigational New Drug application with the 
FDA. This is permission to hold clinical trials using humans. After completion of these 
human trials, the research and all information gleaned from the clinical trials is submitted 
to the FDA for final approval. If approved, the drug is then allowed to be marketed to the 
general public.) 
67 Id.  
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drug is labelled appropriately and isn’t causing adverse reactions with 
consumers.”68 FDA regulation does not stop at approval; “there is also a multi-
tiered activity level in place to provide continuous safety.”69 
Dietary supplements are regulated – it is not a free for all market where 
manufacturers can do what they please. The FDA is in charge of regulating dietary 
supplements in many different ways. They do the following: (1) The FDA 
monitors the marketing claims made by dietary supplement companies; making 
sure that those companies do not claim that their products prevent, reduce the 
symptoms of, or cure diseases. 70  (2) The FDA reviews and approves the 
introduction of new ingredients to the market by affirming generally recognized 
as safe (GRAS) status, or as new dietary ingredients (NDI).71 (3) If the evidence 
indicates an ingredient is harmful, the FDA establishes supplement label warning 
requirements and – if necessary – mandates removal of an ingredient from the 
market place.72 (4) The FDA inspects manufacturing facilities to make sure that 
they follow Current Good Manufacturing Practices (CGMPs).73 (5) The FDA’s 
CGMPs cover everything from raw material verification to finished product 
testing and accurate labelling.74 CGMPs are the most efficient and effective way 
in which the FDA manages to control supplements.75 CGMPs do impose higher 
standards and look to increase the likelihood that supplements are produced in a 
quality manner and are accurately labelled.76  
 
68 Id. 
69 Id.; See also Susan Thual and Agata Dabrowska, How FDA Approves Drugs and 
Regulates Their Safety and Effectiveness, CONGRESSIONAL RESEARCH SERVICE (2018) 
https://fas.org/sgp/crs/misc/R41983.pdf (The FDA regulates new drugs through a multi-
tiered activity record that takes into account: product integrity, labeling, reporting, 
surveillance, drug studies, risk management, information dissemination, off-label use, 
and direct-to-consumer advertising. From changes to the way the drug is marketed to 
label changes or warnings to a drug being pulled from the market entirely, the actions of 
the FDA control the fate of medications across the country.) 
70 The FDA and Dietary Supplements: How Supplements are Regulated, NOW 
https://www.nowfoods.com/now/nowledge/fda-and-dietary-supplements-how-
supplements-are-regulated (last visited Oct. 9, 2019). 
71 Id.  
72 Id.  
73 Id. 
74 Id. 
75 Id., (“[W]hile the FDA expects manufacturers of dietary supplements to comply with 
CGMPs, the FDA does not certify companies to be in compliance. Instead when the FDA 
inspects a manufacturing facility, it will issue “observations,” identifying deficiencies. 
The manufacturers then need to correct these deficiencies.”) 
76 Current Good Manufacturing Practice in Manufacturing, Packaging, Labelling, or 
Holding Operations for Dietary Supplements, FED. DRUG ADMIN. (2010). 
https://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/
dietarysupplements/ucm238182.htm (“[T]he DS CGMP rule requires persons who 
manufacturer, package, label, or hold a dietary supplement to establish and follow current 
good manufacturing practice to ensure the quality of the dietary supplement and to ensure 
that the dietary supplement is packaged and labelled as specified in the master 
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All of these regulatory techniques in place are great on paper, but they are 
retrospective and only attack the problem once the problem is too large to tackle. 
The FDA’s regulation of drugs attack the problem before the problem is there and 
that is the difference. As it is explicitly stated on the FDA website, the ‘FDA is 
not authorized to review dietary supplement products for safety and effectiveness 
before they are marketed.’ 77  The manufacturers and distributors of dietary 
supplements are responsible for making sure their products are safe before they 
go to market. It is only if a serious problem associated with a dietary supplement 
were to occur, must then manufacturers report it to the FDA as an adverse event. 
The FDA can only take dietary supplements off the market if they are found to be 
unsafe or if the claims on the products are false and misleading.78 
C. Marketing Techniques: Drugs vs. Dietary Supplements 
A comparison of the drugs and dietary supplements marketing efforts shows 
the need to increase and heighten the current regulation in place before a 
supplement will reach the market. In 2015, one recent analysis estimated that 
manufacturers spent approximately $60 billion per year on such marketing, 
including over $4 billion directed at consumers.79  
For years, the FDA has been restricting manufacturers’ promotion of 
prescription drugs in several important ways, including preventing manufacturers 
from promoting their products to treat conditions for which the FDA has not 
determined adequate efficacy or safety (off-label uses).80 However, despite the 
requirement for dietary supplements to follow CGMPs, there are still loopholes 
that manufacturers may wiggle their way through if they wish to get their product 
into the market. The following case excerpt is a worrying example of how a 
manufacturer is able to manipulate the loopholes in the supplement market.  
1. Amarin Pharma, Inc v. FDA 
The facts of the case are pretty simple (especially given it is a drug regulation 
dispute). In 2012, the pharmaceutical manufacturer Amarin received FDA 
approval for a new drug, Vascepa, as an adjunct to diet to reduce triglyceride 
levels in adult patient with severe hypertriglyceridemia.81 Following the approval, 
 
manufacturing record. Dietary supplements containing contaminants or those not 
containing the dietary ingredient represented on the label would be considered adulterated 
or misbranded by the FDA.”) 
77 Dietary Supplements: What You Need to Know, FDA (Nov. 2011), 
https://www.fda.gov/Food/DietarySupplements/UsingDietarySupplements/ucm109760.ht
m.   
78 Id.  
79 Lexchin, The cost of pushing pills: A New Estimate of Pharmaceutical Promotion 
Expenditures in the United States, PLOS MED. 5(1): E1. (2008) 
https://doi.org/10.1371/journal.pmed.0050001.  
80 Aaron Kesselheim, et al., Mandatory Disclaimers on Dietary Supplements Do Not 
Reliably Communicate The Intended Issues, 34 HEALTH AFF. (Mar. 2015). 
https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2014.0515?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed.  
81 Amarin Pharms. Ir, Ltd. v. FDA, No. 15-5214, 2015 U.S. App. LEXIS 21333 (D.C. 
Cir. Dec. 9, 2015).  
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Amarin designed and then discussed an additional two trials to see if Vascepa 
effected triglyceride levels among statin-treated patients with persistently high 
triglycerides and if it actually reduced major cardiac events. The latter trial was 
denied by the FDA and they rescinded its prior agreement to allow Amarin to 
market the drug as doing so. The FDA notified Amarin that any effort to market 
Vascepa for this unapproved use could constitute misbranding under the FDCA. 
Amarin took the FDA to court, seeking a preliminary injunction preventing the 
agency from taking any action against the company for truthful, non-misleading 
promotion of Vascepa to health care professionals for patients with persistently 
high triglycerides and it won. The FDA’s concern is with off-label promotion by 
pharmaceutical companies, and it has taken the position that such promotion 
violates the FDCA, even though there is no such proscription in the Act itself. It 
does so by reasoning that off-label promotion amounts to misbranding the drug.  
Without getting into the merits of the case, what really needs to be taken from 
this decision was what the FDA stated in their argument. Counsel for the FDA 
said that, if Amarin repackaged Vascepa as a dietary supplement – Vascepa is 
essentially fish oil -the FDA would not object to including the coronary heart 
disease claim, on certain conditions. What the FDA were saying was that Amarin 
could not promote it to doctors by making truthful coronary heart disease claims, 
but selling it directly to consumers on that basis would be just fine. The Court 
agreed that if Amarin were to label their dietary supplement with a coronary heart 
disease claim, then they would not expose themselves to liability for misbranding 
under the pharmaceutical protocol. As long as Amarin would place a disclaimer 
on the dietary supplement label, then they would be in the clear.  
This case shows the purely illogical rationale behind the FDA and the 
regulations in place for dietary supplements when compared to the exact same 
ingredients and products under the pharmaceutical umbrella. Amarin portrays a 
huge loophole in the system and a clear indication as to why so many 
manufacturers can get their product into the market – potentially harming a huge 
amount of people.   
In response, this paper calls for dietary supplements to go through a multi-
tiered screening and testing process (similar to prescription drugs), meaning gaps 
like the one shown in Amarin can be avoided. This paper calls for a two-step 
process that addresses how dietary supplements reach the shelves. The public can 
be re-assured of the safety and efficacy of what they are taking on a day to day 
basis.    
D. Product Labelling Claims 
Despite not being taken as a replacement for prescription drugs; dietary 
supplements are used to boost general health, and to ward off illnesses.82 However, 
several met-analyses of rigorous efficacy studies report that dietary supplements 
are not effective in either treating or preventing disease. 83  Although certain 
supplements can prevent or treat specific ailments – for example, calcium plus 
vitamin D has been approved to treat osteoporosis – it is unclear whether many 
other supplements offer real health benefits to those without nutrient 
 
82 Reasons of U.S. Consumers to Take Vitamins, Minerals and Nutritional supplements as 
of 2012, STATISTA http://www.statista.com/statistics/308645/reasons-us-consumers-use-
vitamin-mineral-nutritional-supplements/ (last modified Dec. 1, 2012). 
83 Swartzberg, Dietary Supplements Your Complete Guide to Making the Best Choices, 
BERKLEY SCH. OF PUB. HEALTH (2016).  
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deficiencies. 84  Unsubstantiated product-benefit claims in the advertising of 
supplements are driving the market in to the ground, while the pharmaceutical 
market is able to stay afloat due to the stringent regulations supporting it.85  
E. Claims Being Made 
Typically, supplement manufacturers will make two types of benefit claims in 
advertising their product for the public. 
Firstly, they state health claims. Health claims describe an established 
scientific relationship between supplement ingredients and a reduction in the risk 
of a disease or health-related condition. 86  These health claims have a 
substantiation standard applied, meaning competent and reliable scientific 
evidence has to be proven.87 Eventually the health claim has to be evaluated and 
authorized by the FDA prior to marketing.88  
Dietary Supplements are then allowed structure-function claims - regulated by 
21 U.S.C. § 3434(a)(1) and 21 U.S.C. § 3434(r)(6)(13). Structure-function claims 
describe the intended benefit of the supplement on the structure or function of the 
body.89 These claims are the ones that are driving the dietary supplement market 
into the ground because they do not bear the same high evidentiary burden and do 
not require FDA approval prior to marketing.90 The FDA lacks the authority to 
review or approve these claims before the products enter the market. A 
manufacturer must notify the FDA when it uses structure-function claims, and a 
product label must include a disclaimer stating that FDA has not reviewed the 
claim and that the product is not intended to diagnose, treat, cure, or prevent any 
disease.91 
However, if a public survey were to be taken to see whether they actually took 
this disclaimer into consideration, then the majority would answer no.92  The 
reason being is that they see the bottle or the tub of pills/powder on the shelves of 
well-established stores and automatically think that because the store is selling the 
product, then the entirety of the product must have gone through some 
 
84 Rosemary Avery, et al., An Examination of Structure-Function Claims in Dietary 







90 Id.; see also Guallar, et al., Enough is enough: Stop Wasting Money on Vitamin and 
Mineral Supplements, 159 ANN. INTERN. MED. 850 (2013).  
91 OFFICE OF INSPECTOR GENERAL, DIETARY SUPPLEMENTS: STRUCTURE/FUNCTION CLAIMS 
FAIL TO MEET FEDERAL REQUIREMENTS (2012). 
92 (This survey has not been taken yet but it would be extremely interesting to carry out to 
see how ineffective the disclaimer really is on the labels of dietary supplements.)  
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testing/regulation. The plethora of information about dietary supplements at point 
of purchase and in the media is also often unclear, unreliable, and conflicting.93  
F. Availability of Dietary Supplements 
The place of purchase is another aspect to take into consideration because of 
the freedom they have in selling such products. Stores such as GNC and The 
Vitamin Shoppe are everywhere and provide instant access to thousands of 
products that are safe, but at the same time the opportunity is there for unsafe 
products with misleading claims to find their way onto the shelves.94 Although 
GNC started in 1935 and The Vitamin Shoppe opened its doors in 1977, it has not 
been until the last few decades that they have both seen a real surge in customers.  
Dietary supplements were once only associated with bodybuilders, strongmen, 
and professional athletes. The average Joe felt no inclination to take them. It was 
seen as if they were only necessary if you were about to step on the stage at the 
Mr. Olympia. However, as the years have passed and social media has developed, 
people have now started to take supplements upon waking, during work, with their 
food, and before bed – 2019 is a time where the tables have turned. It is seen as a 
rarity if you are not taking at least one form of dietary supplementation. Stores 
such as GNC and The Vitamin Shoppe have taken advantage of the ‘less-informed’ 
consumers by not only selling uncertified products in their store, but also failing 
to advise those consumers of the adverse effects what may arise upon extended 
use.95 
1. Hubert v. Gen. Nutrition Corp. 
In 2017, a class action lawsuit was brought against GNC alleging that they 
knowingly sold products containing unlawful synthetic chemicals to consumers.96 
In Hubert, Plaintiffs alleged that GNC marketed and sold supplements 
manufactured by third party vendors which allegedly contained Picamilon, 
BMPFA or acacia rigidula, despite having known that these substances are not 
dietary ingredients.97 The supplements at issue in Hubert, are primarily weight-
loss and sports nutrition supplements available as powders and liquids. Plaintiffs 
averred that federal and state law place primary responsibility for the safety of 
 
93 Sharon Akabas, et. al, Quality Certification Programs for Dietary Supplements, 116 J. 
OF THE ACAD. OF NUTRITION AND DIETETICS 1370, 1372-1379 (2016).  
94 Company Overview, GNC, https://www.gnc.com/company-overview.html (last visited 
Oct. 9, 2019) (GNC has more than 4,800 retail locations throughout the United States – 
including more than 1,000 franchise and 1,200 Rite Aid store-within-a-store locations and 
franchise operations in 46 international markets); See also About the Vitamin Shoppe, 
THE VITAMIN SHOPPE, http://investors.vitaminshoppe.com/corporate-profile (What began 
as a single store in 1977 has evolved into more than 700 locations in 42 states, the 
District of Columbia and Puerto Rico and an easy to shop web site.) 
95 (Blame is not imputed to GNC and Vitamin Shoppe but the reason that they are 
allowed to sell such products is because they have not been succumbed to the same 
testing as is required for drugs. It can be dangerous with the public spending hundreds of 
dollars at a time on such products and them not getting the instant results that they always 
require.)  
96Hubert v. General Nutrition Corp., No. 15-CV-1391, 2017 U.S. Dist. LEXIS 145506 
(W.D. Pa. Sept. 8, 2017).  
97 Id. at *4. 
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dietary supplements, as well as truthful labelling and advertising, on supplement 
manufacturers and distributors such as GNC. According to Plaintiffs, GNC sold 
products with false and misleading labelling, and further failed to disclose 
material facts about the dangers of ingesting Picamilon, BMPEA, and acacia 
rigidula to consumers. Plaintiffs claimed that they were “hoodwinked” into 
purchasing supplements containing these substances and would not have done so 
if GNC had disclosed that they contained mislabelled ingredients which 
purportedly pose serious health risks and are not marketable as dietary 
supplements.98 The lack of FDA regulation is pivotal to the case - both for the 
Plaintiffs and the Defendant. In 2015, Dr. Cara Welch of the FDA issued a 
declaration stating that “Picamilon does not qualify as a dietary ingredient under 
the FDA act.99 Part of Plaintiffs claim is that they alleged GNC continued to sell 
dietary supplements containing Picamilon until September 21, 2015; despite 
having known since 2007 that it was not a dietary ingredient.  
In terms of acacia rigidula and BMPEA, Plaintiffs further claimed that GNC 
had been aware since the 2013 that some dietary supplements labelled as 
containing acacia rigidula actually contained BMPEA. The significance of this is 
that FDA researchers conducted a study which revealed that many dietary 
supplements purportedly containing acacia rigidula actually contained BMPEA, 
despite no testing to show that BMPEA was safe for humans.100 
Plaintiffs averred that despite GNC’s alleged knowledge regarding Picamilon, 
BMPEA, and acacia rigidula, GNC sold products containing those substances 
which were supplied by third-party vendors. Plaintiffs claimed that GNC 
exercised significant control over the third-party products it sold by reviewing and 
pre-approving labels, warnings, packaging and advertising. By controlling the 
product labels of third party vendors, Plaintiffs alleged that GNC misrepresented 
that supplements containing Picamilon, BMPEA, and acacia rigidula were safe 
for consumers and legal to sell. 101  As a result, Plaintiffs asserted that they 
purchased supplements they otherwise would not have purchased, paid more for 
supplements than they otherwise would have paid and have been subjected to 
unreasonable safety risks.102 
The significance of this case reiterates the FDA’s lack of control from the 
moment a dietary supplement is manufactured right through until it is sitting on 
the shelves of an international store.103 Despite the case being dismissed, it shows 
 
98 Id. 
99 Id. at *5. 
100 Id. 
101 Id. 
102 Id. at *8. 
103 Sheryl Allenson, Failure to allege economic injur-in-facts tanks class ction against 
GNC, HEALTH LAW DAILY (Sept. 11, 2017), 
http://www.dailyreportingsuite.com/health/news/failure_to_allege_economic_injury_in_f
act_tanks_class_action_against_gnc (The court eventually dismissed the action because 
of a lack of injury-in fact. The court found several arguments from the Plaintiffs’ to be 
lacking. Noticeably the court rejected the argument that GNC sold products with false 
and misleading labels and did not disclose material facts. The court stated that “the 
complaint did not allege what those material facts allegedly were or even whether GNC 
had an obligation to so disclose. The complaint also did not allege that the consumers 
were induced to purchase the dietary supplements based on any specific 
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a gap in the industry that needs to be altered in a way to stop companies like GNC 
from taking advantage of the consumer.  
According to the FDA, Picamilon is a substance that does not meet the 
statutory definition of a dietary ingredient. Picamilon is a unique chemical entity 
synthesized from the dietary ingredients niacin and gamma-aminobutyric acid. 
Picamilon is absorbed into the body, crosses the blood-brain barrier and 
accumulates in the brain as a separate chemical entity. Because Picamilon does 
not fit any of the categories of dietary ingredients under the Act, any products 
marketed as dietary supplements that declare Picamilon as a dietary ingredient are 
misbranded.104 
Acacia rigidula is different to Picamilon because it is a new dietary ingredient. 
Acacia rigidula is labelled as a dietary ingredient in some products marketed as 
dietary supplements. However, the FDA is unaware of any information that it was 
lawfully marketed as a dietary ingredient in the United States before October 15, 
1994. Due to the fact there is no history of use or other evidence of establishing 
that the dietary ingredient, when used under the conditions recommended or 
suggested in the product labelling, will be safe for consumers, the product is 
deemed to be adulterated.105 
Finally, BMPEA is also a substance that does not meet the statutory definition 
of a dietary ingredient. While it was listed as a dietary ingredient on the product 
labels (within GNC), BMPEA does not meet the statutory definition of a dietary 
ingredient.106 
The significance of this class action lawsuit being filed is that under existing 
law, including the DSHEA passed by Congress in 1994, the FDA can take action 
to remove products from the market, but they must first establish that such 
products are adulterated or misbranded.107 The publicity that this lawsuit has 
subsequently caused should prove to be the ignition that is needed to get such 
dangerous products off of the shelves which are so easy for consumers to buy. 
The FDA is not the sole regulator and that is the issue in the Hubert case. 
Given the size and diversity of the products and ingredients, the rapid pace with 
which new dietary supplements are introduced into the market, and the fact that 
FDA approval is not required before products are introduced to the market, 
manufactures can get around the obstacles far too easily. 
 
misrepresentation. Nor did it allege that GNC identified its product as superior or identify 
comparable less expensive products to support an argument that an economic injury 
existed in the form of premium prices paid for the GNC supplements.”). 
104 Picamilon in Dietary Supplements, FDA (Nov. 29, 2017), 
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm472881.htm.  
105 Acacia rigidula in Dietary Supplements, FDA (Nov. 29, 2017), 
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm489921.htm.  
106 BMPEA in Dietary Supplements, FDA (Nov. 29, 2017), 
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/ucm443790.htm.  
107 Id. 
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G. Third-Party Certification Programs 
As noted, there are independent third-party certification programs that offer 
quality assurance for dietary supplements in the market place.108 However, third-
party certification/verification programs are not universally used by the dietary 
supplement industry; they are fee-based programs and participation is 
voluntary.109  
ConsumerLab.com, NSF International, and US Pharmacopeial Convention are 
three of the largest and most notable third-party organizations who test dietary 
supplements as finished products - pills, powders, liquids, drinks, and sport and 
energy products.110 Quality certification by these companies ensure that these 
supplements do not contain harmful levels of toxic botanical species, or greater or 
lesser amounts of active or marker compounds than indicated on the product 
specification and label. NF-USP was discussed earlier in this paper which leads 
to the importance of ConsumerLab.com.  
Starting in 1999, the ConsumerLab.com Quality Certification Program was 
the first national third-party verification program for dietary supplements.111 A 
difference of the ConsumerLab.com is that it does not accept products directly 
from the manufacturer; instead it purchases products from the marketplace and 
the products must comply with FDA labelling requirements, must disclose 
necessary information about each ingredient (such as the correct plant name and 
plant part in botanical products), and can only display allowed product claims. 
Although the results of these tests (pass or fail) are proprietary and confidential to 
the manufacturer; if the product meets test standards, manufacturers can license 
the use of the ConsumerLab.com seal of approval to use on their product labels, 
packaging, advertising, and marketing. However, in order to continue to carry the 
CL Seal directly on product labelling, the product must pass retesting every twelve 
months.112 One thing extraordinary about ConsumerLab.com is that it indicates 
when the recommended serving size for a nutrient exceeds the Tolerable Upper 
Intake Level established by the Institute of Medicine of the National Academies.  
The alternate to ConsumerLabs.com is NSF International. According to the 
website, manufacturers, regulators and consumers look to NSF International for 
the development of public health standards and certification programs that help 
protect the world’s food, water, consumer products and environment.113 Like a CL 
Seal, NSF International has a mark on products that have been tested and 
subsequently passed the procedure. The NSF mark is the assurance that the 
product has been tested by one of the most respected independent certification 
organizations in the world. It means that the product contains the ingredients listed 
on the label in the declared potency and amounts; it does not contain harmful 
levels of specified contaminants, including >200 athletic banned substances for 
 





113 The NSF Mark, THE PUB. HEALTH AND SAFETY ORG. http://www.nsf.org/about-nsf/nsf-
mark (last visited Oct. 9, 2019).  
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Certified for Sport products, and it has been manufactured according to FDA’s 
current CGMPs.114 
These third-party certification programs are not mandatory for manufacturers 
of dietary supplements to follow.115 It is therefore no wonder that cases such as 
Hubert are being brought forward against large stores such as GNC. It is all too 
easy for manufacturers to mislabel their products, as the chances of them being 
caught by consumers is low. People generally do not go into a store searching for 
ingredients that they know are banned. They merely see what they want on the 
TV or on the Internet, and then proceed to their local supplement store. On the 
other side of the spectrum is the blind eye that these stores show towards the array 
of supplements that come through their doors. As illustrated by the Hubert case, 
GNC do not have a protocol in place to wire out any misbranded supplements. 
Assuming that The Vitamin Shoppe have similar standards in place, that means 
that every general American wishing for that quick fix will generally have no 
inclination that they may end up buying a product that could be detrimental to 
their health. The employees are at no duty to warn customers of the effects, 
because they too have no idea whether an ingredient is banned or whether a dietary 
supplement has conformed with the FDA’s regulation protocol. 
V.  THE PROPOSAL 
A new form of regulation; one that takes the pressure away from the FDA 
needs to be established. The public is at the risk of continuous danger as the 
market continues to grow. A multi-tiered regulating system is needed to ensure 
that the public - who are currently being preyed on by manufacturers – can be 
confident that what they are putting into their body has been tested, tested, and 
tested again before they ingest.  
Currently, consumers like the freedom in being able to ‘one-click purchase’ 
vitamins, powders, and pills from an array of websites. A majority of the public 
believe that the government do not, and should not decide what can and cannot be 
on the market, and that consumers should have some say in the process.116 Many 
believe (especially individuals who take supplements day in and day out), that if 
a supplement were to be really harmful, then the market will eventually speak and 
there will be no demand for it.117 The counter-argument on the other side of the 
spectrum is that if there were to be no regulation what so ever, then consumers 
may be harmed by the ingestion of harmful supplements.118 This follows on from 
the idea that they need to be regulated in a way that is very similar to prescription 
and OTC drugs.  
Imagine living in a world where manufacturers such as Pfizer Consumer 
Products (a major pharmaceutical company), had the option of getting pills such 
as ‘Advil’ or ‘Viagra’ onto the market through a lack-lustre testing regime that 
had no implications what so ever. Would the public still feel inclined to reach for 
their dose of Advil to help combat an inflammation? Or would they be so willing 
to reach for a ‘Viagra’? The answer to these two example questions are 
 
114 U.S. Pharmacopeia, supra note 57. 
115 Id. 
116 Sax, supra note 14 at 379.   
117 Id. 
118 Id. 
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undoubtedly no. But if you were to switch the variables around and replace ‘Advil’ 
and ‘Viagra’ with ‘Pre-Workout Powder’ and ‘Weight Loss Pills’ then because of 
the freedom that consumers have on the market, they will be more willing to try 
the product despite them not going through the same testing process as the 
NSAID’s and sexual enhancers. Just as the FDA is charged with securing a safe 
food and drug supply, the FDA should have the same ability to ensure a safe 
dietary supplement supply.119 A somewhat distant analogy can further be made 
with cigarettes. Consumers want the autonomy and freedom to purchase as many 
cigarettes as they want, all in the face of the data that demonstrates the life-
threatening health risks that they pose. Cigarettes go through extensive regulation, 
yet consumers still enjoy the autonomy. Dietary supplements on the other hand 
go through about half of that regulation, yet consumers still want and are able to 
enjoy the same autonomy and freedom. 
A. The Classification Phase 
Currently, the FDA’s definition of Dietary Supplements includes a wide array 
of products that many people may feel to be overwhelming.120 For example, a 
supplementary Vitamin C tablet has far less ingredients than a ‘pre-workout’ 
supplement.121 Until recently, Jack3d was a popular pre-workout among body-
builders and college gym goers who wanted that crazy boost of energy.122 With 
no relative comparison, it is crazy to think that these two should go through the 
same testing/regulation process. This is an example of why in the future, although 
the term “Dietary Supplement” as used by the FDA is the catch all phrase, those 
within that category, need to be split up into separate divisions so that they can be 
regulated accordingly. The disparity in the repercussions of ingesting ascorbic 
 
119 Id. 
120 Dietary Supplement Products & Ingredients, FDA (Nov. 20, 2018), 
https://www.fda.gov/Food/DietarySupplements/ProductsIngredients/default.htm (The 
Federal Food, Drug, and Cosmetic Act “defines a dietary ingredient as a vitamin; 
mineral; herb or other botanical; amino acid; dietary substance for use by man to 
supplement the diet by increasing the total dietary intake; or a concentrate, metabolite, 
constituent, extract, or combination of the preceding substances.”) 
121 Chad Bjorklund, Ingredients of Vitamin C Tablets, LIVESTRONG, 
https://www.livestrong.com/article/285497-ingredients-of-vitamin-c-tablets/ (“[W]hile 
particular formulations of vitamin C tablets may differ slightly among competing 
manufacturers’, the primary ingredient should be raw ascorbic acid. Vitamin C tablet 
makers utilize raw ascorbic acid that is either extracted from plants like corn, or 
chemically synthesized. Those Vitamin C tablets that do not have ascorbic acid as the 
primary ingredient are marketed as special vitamins or multi-vitamins. However, 
consumers should be aware of the filler ingredients. Filler ingredients may include but are 
not limited to: vegetable or magnesium stearate, methylcellulose, glycerol and silica. 
These agents are considered non-active ingredients because they are not expected to have 
any negative or positive impact on your health.”) 
122 Jack3d Ingredients, JACK3D http://www.jack3d.org/ingredients (The famous ‘lethal’ 
pre-workout ingredients were: arginine Alpha-Ketoglutarate, Creatine Monohydrate, Beta 
Alanine, Caffeine, 1,3-Dimethylamylamine HCL, Schisandra Chinensis Extract, Citric 
Acid, Silicon dioxide, Acesulfame Potassium, Sucralose, Vegetable Stearate, and Beta 
Carotene.) 
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acid123 as compared to dimethylamine is worrying.124 This incongruence calls for 
vitamins and minerals etc., to go through alternate testing regimes. Whereas 
supplements which have the potential to have the same effect as amphetamines 
should obviously go through more rigorous testing to ensure that the standards 
being met are of the highest degree. The difference in testing is for two reasons: 
(1) consumer safety and (2) consumer awareness. Ascorbic acid can be tested 
relatively quickly and efficiently. Dimethylamine on the other hand would require 
a larger subject group because of the detrimental effects that it may induce.  
This paper recommends that there be five tiers within this first ‘classification’ 
phase. Tier one being the lowest form of testing and tier five having to go through 
a laborious period which could delay the product from reaching the shelves for 
months and even years. Manufacturers must submit what they feel their product 
is before any testing is done. Once manufactures have submitted their preferred 
tier, those in charge of testing at the designated organization shall look to the 
current side effects of each ingredient within the proposed supplement and 
determine based on the severity of such side effects, whether that tier is applicable. 
When submitting their preferred tier, a manufacturer must provide testing 
methodology to support their position. Alternatively, if they fail to provide such 
evidence, then their product will automatically be placed into tier five for the sake 
of protecting the public.  
Any products which have already shown a significant relationship with death, 
abnormalities in child birth etc., will automatically be banned from ever being 
administered into phase one. Again, this is purely for the safety of the consumer, 
as for too many years they have been the scapegoat for many companies. The 
FDA has been making blind choices; for example, when they see ingredients such 
as dimethylamine on a tub of pre-workout that is labelled as “the best pump 
guaranteed,” they quickly disengage the doubt and adhere to whatever the label 
says.  
B. Post-Classification Tier for Testing 
Once manufactures have been placed into the tier for their product to be tested, 
they must then decide and further prove what category of dietary supplements 
they wish to be defined as. Categories include but are not limited to: bodybuilding 
supplements, energy drinks, energy food products, nutritional supplement 
companies, relaxation drinks, sports nutrition and body supplements, and vitamins 
and minerals.125 If a manufacturer does not fit into one of these categories, they 
must then establish the category that they wish to defined under – again supported 
by scientific data.126 
 
123 Vitamin C, OFFICE OF DIETARY SUPPLEMENTS 
https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/ (last visited Oct. 9, 2019) 
(Vitamin C, also known as ascorbic acid, is a water-soluble nutrient found in some foods. 
n the body, it acts as an antioxidant, helping to protect cells from the damage caused by 
free radicals. Free radicals are compounds formed when our bodies convert the food we 
eat into energy.) 
124 Avery, supra note 84 (For example, multiple deaths have been associated with a work-
out booster called “Jack3d,” which contains dimethylamine, described by the medical 
literature as a synthetic stimulant similar to amphetamines.) 
125 Dietary Supplements, WIKIPEDIA 
https://en.wikipedia.org/wiki/Category:Dietary_supplements (last visited Oct. 9, 2019). 
126 Id.; see also Dietary Supplements for Weight Loss, NAT’L INSTITUTE OF HEALTH 
https://ods.od.nih.gov/factsheets/WeightLoss-HealthProfessional/ (last visited Oct. 9, 
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The reason for this classification is the transparency that such would bring to 
the consumers. On the labelling for each product would indicate which tier that 
the product is in. If a pre-workout supplement is in Tier four within the first phase 
and under “bodybuilding supplement” in the second phase, then that is exactly 
what is to be shown to those who will be buying such a product. 
C. Labelling Requirement 
The ingredients and the effects of the supplement on the body are only a 
portion of why someone ends up buying it. The other half is the marketing and 
how such a supplement has been branded to the public. The government’s right to 
restrict off-label promotion has been the subject of criticism in the past.127 This 
was amplified in US. v. Caronia, a Federal Circuit Court of Appeals case.128 Under 
the DSHEA that was passed in 1994, there is somewhat of a combative measure 
against frivolous claims because health-related statements made for dietary 
supplements must be accompanied by a standard disclaimer: “This statement has 
not been evaluated by the Food and Drug Administration. This product is not 
intended to diagnose, treat, cure, or prevent any disease.”129  
Not only will this statement be no longer needed with this reform, but any 
statement that has not been evaluated by the governing body will not be sold under 
the umbrella that is dietary supplements. All statements must be evaluated and 
proven by the determined organization and the manufacturer respectively.  
D. The Federal Trade Commission’s Role 
Currently the FTC regulates dietary supplement advertising; it has the primary 
responsibility for monitoring claims in advertising, including print and broadcast 
advertisement, infomercials, the Internet, catalogues, and similar direct marketing 
materials.130 Because the FTC and FDA have shared jurisdiction for advertising 
claims, they often work together on enforcement activities. This should not be a 
requirement. This reform recommends a deviation from all of the different 
 
2019) (For example, “if a manufacturer were to list their supplement in the ‘Weight-Loss’ 
category, they must be able to prove that active weight loss ingredients such as: African 
mango (irvingia gabonensis), beta-glucans, bitter orange, caffeine, calcium, capsaicin, 
carnitine, chitosan, chromium, coleus forskohlii, conjugated linoleic acid, fucoxanthin, 
garcinia cambogia, glucomannan, green coffee bean extract, green tea, guar gum, hoodia, 
probiotics, pyruvate, ketones, vitamin D, Phaseolus vulgarius and yohimbe are not 
combined with other active ingredients that mask the effects such as benzodiazepines and 
anti-depressants which mask the side effects of those listed stimulants within the same 
pill.”) 
127 Kesselheim, FDA Regulation of Off-Label Drug Promotion Under Attack, 309 JAMA 
445 (2013) https://www.ncbi.nlm.nih.gov/pubmed/23385267. 
128 U.S. v. Caronia, 703 F.3d 149 (2nd Cir. 2012) (the Court held that the First 
Amendment of the US Constitution protects off-label promotion by manufacturers and 
their sales representatives as a form of commercial speech, as long as the marketing is not 
overtly false or misleading.) 
129 Regulations on Statements Made for Dietary Supplements Concerning the Effect of the 
Product on the Structure or Function of the Body, 65 Fed. Reg. 1000, 1001 (Jan. 6, 2000) 
(to be codified at 21 C.F.R. pt. 101).  
130 FEDERAL TRADE COMMISSION, DIETARY SUPPLEMENTS: AN ADVERTISING GUIDE FOR 
THE INDUSTRY (2001). 
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organisations with the sole responsibility embedded into one. By requiring 
manufacturers to support that their label does what it says to a high percentage of 
certainty will give the FDA and the FTC some breathing space. Requiring proof 
to be submitted before the product goes on sale will lower the amount of frivolous 
claims being made by individuals who often moan about the 10lbs not being lost 
in 10 days. Such claims will not be made as often because such assertions will not 
be authorised to be on a bottle of weight loss pills unless a reliable study has 
shown that such an effect is highly probable.  
The current situation of the market allows for the companies to make 
advertisements and statements pointing to certain side effects. This is because in 
1998, the Federal Trade Commission published a guidance document that 
contained nonbinding recommendations that advertisements need not meet any 
preapproval standard.131 The difficulty in there being no “black letter law” for 
regulators or the industry to follow is that when dealing with a claim, courts have 
so much discretion in deciding whether an advertisement claim is misleading or 
not. What courts have to decide between is the First Amendment rights of a 
company versus the “potential”, “weak, non-individualized injury suffered by the 
plaintiff.” It is of no surprise that in recent years, courts have shifted from a 
position of protecting the consumer to now favoring the supplement manufacturer 
and marketer.132 What is remarkable is that courts often find the First Amendment 
to prevail in such situations because they feel that inconclusive, unsupported 
health claims are not enough to meet the ‘misleading’ threshold. If a company 
places a disclaimer, then they are to be protected by commercial free speech 
despite the disclaimer being used in support of an unsupported claim.133 
E. Disclaimer Requirement 
As demonstrated, manufacturers currently have a duty to place a disclaimer on 
their product to ensure that they are not “misleading” the consumer. However, this 
is somewhat of an oxymoron because the disclaimer is being used as a safety net 
for the statement that is misleading in general. They do it in such a way to cover 
their tracks and to relinquish any liability if someone were to be negatively 
affected by taking their supplements. How often have you seen the statement on 
a tub of protein or a container of vitamins that says, “This statement has not been 
evaluated by the Food and Drug Administration. This product is not intended to 
diagnose, treat, cure, or prevent any disease.” An example of an untested product 
using such a claim would be on any weight loss pill. If the statement on the front 
said – “this product promotes healthy weight loss,” then this is suitable under 
current regulations. However, because it has not been tested it cannot say that 
“this product will lose you pounds.” The manufacturer would only have to add 
that disclaimer to the bottle and now the supplement industry has won in being 
 
131 Id.; see also Vilafranco, Regulation of Dietary Supplement Advertising: Current 
Claims of Interest to the Federal Trade Commission, J. OF FOOD DRUG LAW (2007), 
https://www.ncbi.nlm.nih.gov/pubmed/18557227.  
132 Nguyen, Potential FTC restrictions on diet advertising, J. OF FOOD DRUG LAW (2008); 
See also J. Zigler, A Free Market for Dietary Supplements: Issues Surrounding DSHEA’s 
Exceptions to the Labelling Exemption for Third-Party Literature, J. OF FOOD DRUG LAW 
(2007), https://www.ncbi.nlm.nih.gov/pubmed/17444029.  
133 Marlys J. Mason et al., The Impact of Warnings, Disclaimers, and Product Experience 
on Consumers’ Perceptions of Dietary Supplements. J. CONSUM. AFF. (2007), 
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1745-6606.2006.00069.x.  
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able to state that an untested product promotes health weight loss merely because 
it contains a disclaimer. People are unaware that the disclaimer used means that 
these products are not in fact drugs, and do not carry the same level of regulation 
by the FDA, nor likely the same weight of scientific evidence.134 A disclaimer 
signals to the consumers that it is up to them whether they want to take that 
supplement and up to them whether they believe the product will benefit their 
health and is safe for them to take.135 A disclaimer provides that the government 
– specifically the FDA – does not vouch for its effects, but it is not saying that the 
supplement does not work at all.  
In a study conducted by the Associate Professor of Medicine at Harvard 
Medical School, a survey was propounded upon the public to get their take and 
beliefs on what a disclaimer on dietary supplements really does – or what they 
believed it to do. Three example questions were very consistent with the points 
that have already been made in this paper. (1) Question: Do supplement users have 
differing perceptions of safety, efficacy, and regulatory oversight of dietary 
supplements than nonusers? (1) Answer: Despite the presence of a disclaimer, 
approximately 50% of respondents believed the FDA approves dietary 
supplements for safety and efficacy. Younger respondents, minorities, and less 
educated respondents were more likely to misunderstand the FDAs role in 
regulating dietary supplements. 136  (2) Question: What are consumers’ 
comprehensions of dietary supplement label information? (2) Answer: Consumers 
misunderstood the disclaimer language, with 40% believing the disclaimer meant 
that insufficient research had been done to prove the claimed benefits. Consumers 
also misunderstood the FDA’s role in regulating dietary supplements, with 33% 
believing the disclaimer meant that the product was not approved or regulated by 
the FDA. In addition, 18% believed that the DSHEA disclaimer protected the 
FDA from legal action.137 (3) Question: How do consumers interpret information 
on dietary supplement materials? (3) Answer: Despite nearly universal awareness 
of the FD disclaimer, many participants believed that supplements’ claims were 
FDA-reviewed and distrusted the FDA’s ability to effectively regulate health 
products. Health risks of supplements were generally ignored. The disclaimer did 
not change the FDA’s role in approving dietary supplements.138 
 
134 Why “this Statement” Isn’t Evaluated by the Food and Drug and Administration, 
ELYSIUM HEALTH (Oct. 2017), https://endpoints.elysiumhealth.com/fda-disclaimer-
explained-5738f7aba0d5.  
135 Id., (The Officer of Inspector General, in a report on effective labelling, notes that 
such a strong, clear disclaimer on supplement labels is meant to balance out any 
marketing claims made by supplement brands. But in effect, experts like Nestle say, the 
disclaimer is a signal from the FDA that it is up to consumers to decide whether a 
supplement will benefit their health and is safe for them to take. “The disclaimer is the 
FDA’s way of showing its lack of responsibility,” Nestle says.) 
136 Pillitteri, supra note 18. 
137 Carla Miller & Tony Russell, Knowledge of Dietary Supplement Label Information 
Among Female Supplement Users, PATIENT EDUC. COUNS. (2004), 
https://www.ncbi.nlm.nih.gov/pubmed/14998599.  
138 Marlys J. Mason, Unintended Consequences of Health Supplement Information 
Regulations: The Importance of Recognizing Consumer Motivations, J CONSUM. AFF. 
(2011), 
https://www.researchgate.net/publication/230459231_Unintended_Consequences_of_He
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When taken in context of what has already been discussed, it seems that 
disclaimers in the dietary supplement world are not only irrelevant for warning 
consumers, but they also seem to mislead consumers into thinking that the 
manufacturer has complied with “any and all” regulations that are currently in 
place for their product to be on the shelves. In support of these answers from the 
surveys taken, it is explicitly clear that the disclaimer currently required is not 
needed on dietary supplements. This is correct because all dietary supplements 
will be going through a rigorous classification/regulating period so that all 
products have in fact been tested by an organizational body. An alternate 
statement on dietary supplements should be required to inform the buyer that the 
product has gone through testing and regulation. 
Dietary supplements should follow the recent decision by the FDA to enhance 
the medical information on prescription drugs. 139  Currently, prescription 
medications do not have disclaimers because they are tested rigorously by the 
FDA. However, there are many requirements for those manufactures to meet if 
they decide that they want to advertise their product on the television, radio, or 
internet.  
According to the FDA, different advertisements require different amounts of 
benefit and risk information.140 For example reminder ads do not have to include 
any risk information because they cannot include any claims or pictures about 
what a drug does or how it works. Reminder ads are only for drugs without certain 
specified serious risks. (Ibuprofen could be used in a reminder ad if the ad did not 
describe or name the condition that ibuprofen treats or make dosage 
recommendations.) 141 The next classification is print product claim ads – these 
may make statements about a drug’s benefit(s). They must present the drug’s most 
important risks in the main part of the ad (fair balance). These ads generally must 
include every risk, but can present the less important risks in the detailed 
information known as the brief summary.142 Print product claim ads and reminder 
ads must include a disclaimer just like dietary supplements are required to. 
However, the difference in the context of the disclaimer is worrying for dietary 
supplement users. Print product claim and reminder ads must include the 




139 The FDA Announces New Prescription Drug Information Format, FDA (Dec. 4, 
2015), 
https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/LawsActsandRu
les/ucm188665.htm (In January 2006, the FDA unveiled a major revision to the format of 
prescription drug information, commonly called the package insert. To manage the risks 
of medication use and to reduce medical errors, the newly designed package insert will 
provide the most up-to-date information in an easy-to-read format that draws physician 
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prescription to the FDA. Visit MedWatch or call 1-800-FDA01988.” The FDA 
wants to know about side effects, they retain some sort of responsibility with their 
product. They want to ensure that the public are in the safest hands possible when 
it comes down to prescription medication ingestion. Whereas when compared to 
the disclaimer listed on dietary supplements – the FDA is relinquishing any 
responsibility by unequivocally stating that this “product has not been tested.”  
New regulation would be advantageous because it would put that lost 
responsibility back into the regulator and/or the organization in charge of the 
testing methods. The public and the consumers would now have an easy avenue 
to proceed down if they were to experience any irrational side effects. Currently, 
those disclaimers placed on prescription drugs have caused the U.S. Government 
to investigate illegal off-label marketing efforts by manufacturers and 
subsequently they have dished out approximately $15 billion worth of civil and 
criminal fines.143 The dietary supplement industry does not have the capacity to 
order such fines because there is no background to support the allegations. 
Manufacturers therefore look for gaps in the market, pounce upon that gap, and 
subsequently take advantage of the consumer as they know that it is unlikely that 
they will be reported – and if they were to be reported, the odds of a fine/penalty 
in the same pedigree as prescription drugs is unimaginable. Dietary supplement 
companies and manufacturers currently have a two-strike rule. It is not until the 
second offense that they are to be punished.144  
F. The Marketable Product 
Currently, dietary supplement manufacturers can claim anything not seriously 
misleading on their product. However, there are three main categories of claims 
that are defined by statute and/or FDA regulations: health claims, the nutritional 
content, and structure/function claims.145  
Health claims describe a relationship between a food substance (dietary 
supplement ingredient), and a reduced risk or a disease or a health-related 
condition. A health claim lacking these two requirements does not meet the 
regulatory definition of a health claim.146 Health claims are currently regulated by 
the FDA because of the potential effect that they can have on the consumer buying 
the product. There are currently three ways in which the FDA exercises its 
oversight in determining which health claims may or may not be used on dietary 
supplements.147  
(1) The 1990 Nutrition Labelling and Education Act provides for the FDA to 
issue regulations authorizing health claims for foods and dietary supplements after 
reviewing and evaluating the scientific evidence, either in response to a health 
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claim petition or based on its own initiative.148 The FDA authorizes these types of 
health claims based on an extensive review of the scientific literature, generally 
as a result of the submission of a health claim petition, using the significant 
scientific agreement standard to determine whether the substance/disease 
relationship is well established.149  
(2) The 1997 Food and Drug Administration Modernization Act (FDAMA) 
provides for health claims based on an authoritative statement of the National 
Academy of Sciences or a scientific body of the U.S. government with 
responsibility for public health protection or nutrition research; such claims may 
be used 120 days after a health claim notification has been submitted to FDA, 
unless the agency has informed the notified that the notification does not include 
all the required information.150 However, this method cannot be used for dietary 
supplements at this time.151 
(3) As described in FDA’s guidance entitled Interim Procedures for Qualified 
Health Claims in the Labelling of conventional Human Food and Human Dietary 
Supplements, the agency reviews petitions for qualified health claims where the 
quality and strength of the scientific evidence falls below that required for FDA 
to issue an authorizing regulation.152 This is used when there is emerging evidence 
of a relationship between a food substance and reduced risk of  disease or health-
related condition, but the evidence is not well enough established to meet the 
significant scientific agreement standard required for FDA to issue an authorizing 
regulation. The qualified health claims petition process provides a mechanism to 
request that FDA review the scientific evidence and exercise enforcement 
discretion to permit the use of the qualified claim in food labelling. 153 
Not only do dietary supplements contain health claims but they also contain 
nutrient content claims. The nutrient content claim describes the level of a nutrient 
in the product, using terms such as free, high, and low, or they compare the level 
of a nutrient in a food to that of another food, using terms such as more, reduced, 
 
148 Id., See also Authorized Health Claims That Meet the Significant Scientific Agreement 
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and light.154 An example of this would be when a dietary supplement states, “a 
good source of Vitamin C,” or “high in antioxidants”.155 
Finally, manufacturers may include structure/function claims. These claims 
describe the basic benefits of the product on a particular area or function of the 
body. Examples would be, “helps support lower cholesterol,” or “helps maintain 
fluid joints.” Structure/function claims must include a disclaimer to state that they 
have not been evaluated by the FDA.156 
Taking into account that these are the only three claims to be regulated by 
statute and/or the FDA, it is far too confusing of a protocol to go through for every 
product out there. It is why there are currently thousands of bottles on the shelves 
of supplement stores and online that choose not to fall into one of these so that 
they end up this process. However, with new regulation, all claims, no matter what 
it says shall be evaluated and checked against the science. With the leeway that 
manufacturers currently have, they swarm their products onto the public with 
claims that are sometimes inevitably too good to be true.  
From now on the labels on dietary supplements will be far easier to understand. 
Packaging and labels shall be limited in the amount of information that they can 
provide. Sales will be based on actual health benefits as opposed to the 
marketability of a product claiming to be the “number one weight loss pill in the 
U.S.” By limiting packaging to stating the name of the product, the ingredients, 
the nutritional values (RDA if available), and a regulated description/statement on 
what the product does; consumers will be in the driving seat as opposed to the 
companies. People will be buying based on the information available that has been 
supported, not on frivolous claims.  
Currently, the majority of dietary supplements include the disclaimer that 
there claim has not been evaluated by the FDA. This statement or “disclaimer” is 
required by the DSHEA when a manufacturer makes a structure/function claim 
on a dietary supplement label. The reason that a disclaimer is required is because 
the manufacturer is the one who is responsible for ensuring the accuracy and 
truthfulness of these claims. The law of the DSHEA states that if a dietary 
supplement contains such a claim, it must in a “disclaimer” that FDA has not 
evaluated this claim. The disclaimer must also state that this product is not 
intended to “diagnoses, treat, cure or prevent any disease,” because only a drug 
can legally make such a claim.157 As a consumer, seeing this can be daunting, 
scary and confusing. Especially seeing as a portion of the public believes that 
supplements are regulated like drugs. With this new reform that this paper is 
proposing, there will be no need to have such a disclaimer on the product. The 
manufacturers would have gone through scientific testing, similar to how drugs 
are. Despite the reform not requiring that diet supplements go through the exact 
same protocol as drugs; supplements will be proven safe before they go onto the 
market. Thus, no such disclaimer will be required. The only statement from the 
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FDA that will be on dietary supplements will be that the product has been tested 
and has been proven to be safe.  
A current regulation in place at the moment that is beneficial and should 
remain in some shape or form is the capability of the public, or a health care 
provider, to report a problem or illness caused by a dietary supplement to the 
FDA. 158  Even though the protocols to file such a claim have already been 
discussed in this paper, it is important to make it as easy as possible to file. When 
it comes to reporting adverse events or problems, people are often worried that 
what they are reporting is not linked to the dietary supplement or it was all part of 
the side effects that were likely to happen. With the new reform in place, the public 
should be at ease in reporting as they can now be confident that the product has 
been tested and therefore any adverse events should be reported.  
If a diet supplement gets reported through this new reform, then at least the 
FDA can say that the product was tried and tested before it reached consumers. 
They may be more aware of the potential effects, what can be changed with the 
dietary supplement, and whether or not removing it from the market before the 
problem is solved is the most feasible idea. Problems should be easy to report, but 
this new reform shall place barriers in place to prohibit frivolous claims being 
made. However, frivolous claims are often made when a dietary supplement has 
not done what it said it is meant to do on the label. This is where the new reform 
will prove to be beneficial because such claims cannot be made unless they have 
been proven in the pre-approval stage before being allowed to be sold to the public. 
The new reform will also continue to publish on a quarterly basis data that was 
extracted from the agency’s adverse event reporting system.159 These quarterly 
reports will continue to include the adverse events that were submitted by 
consumers, medical professionals and the industry for those three months. 160 
Having such a platform available to the public will enable them to (1) check out 
a diet supplement before they purchase it and (2) when they want to report a claim 
then they can check if someone has reported an adverse event already that is 
similar to theirs. If someone has, then this should raise a red flag when they report 
it again to the FDA. If a dietary supplement ends up having a certain amount of 
reports within a certain time period for the same adverse event or problem, then 
that supplement shall be immediately removed from the market until the FDA has 
proven that it is safe for human consumption. 
The final important aspect of this reform will be current medical professionals’ 
ability to prescribe dietary supplements for those who are lacking vital nutrients 
and minerals either in their diet or lifestyle. The reason that this will be attainable 
is because doctors and physicians will now be prescribing supplements that have 
been tried, tested, and proven to be safe by the FDA. There will be no liability 
attached to them for prescribing a supplement that has met the required testing 
protocols. Currently, doctors can prescribe certain weight loss pills but these pills 
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are classified as drugs.161 However, they usually only prescribe them only if your 
BMI is 30 or higher, or if it’s at least 27 and you have a condition that may be 
related to your weight, like type 2 diabetes or high blood pressure.162 Common 
prescription weight loss drugs include: Orlistat, Belviq, Contrave, Saxenda, 
Phentermine, and Qsymia.163 The problem with this, is that people are often scared 
about approaching a doctor because of either the cost of going to see one (people 
without insurance) and/or the embarrassment about seeing one about their weight. 
It is far easier for them to walk into a GNC or a Vitamin Shoppe where there is 
no embarrassment attached whatsoever in picking up the fanciest looking diet pill 
tub and paying very little money for something that has not been tried and tested 
by the FDA.  
This paper is calling for the ability to be given to doctors to prescribe diet 
supplements. They will be cheaper for the consumer, they will be covered by 
insurance in cases where the patient actually needs them, and the doctor will know 
that what he/she is prescribing will not adversely affect their liability if such a 
supplement does not work. Transparency will be higher and medical professionals 
will know exactly what diet supplements have the highest success and safety rate. 
VI.  CONCLUSION 
The intake of diet supplements has increased astronomically within the past 
decade and the future looks to be heading in the same direction. The ease in which 
the public can go to a store or visit a website to buy such supplements is extremely 
worrying. Given the lack of testing that gets done before they are available to 
purchase, the FDA along with other agencies of the Government, need to take 
action and stop with the retrospective attitude to such an important situation.  
This paper shows that the current regulations in place are lacking given the 
ease in which supplements are obtained by the public. If the regulation currently 
in place were to remain for the next decade, then not only would there be tens of 
thousands of more products on the market, but the claims which those products 
would be making would continue to take advantage of the consumer. The less 
educated percentage of the population are not aware of the implications that may 
arise from taking such a product that claims to be the best in the market for 
achieving a certain result. Through a combination of the points that this paper has 
laid out, a reform will cause consumers to feel safer and more aware of the effects 
when picking and choosing a supplement which they hope will aid them in their 
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